Abstract
Background
Inflammatory bowel diseases (IBDs) are a group of chronic diseases affecting the gastrointestinal tract, with a disabling course. The incidence of IBDs is increasing in different geographical areas, indicating its emergence as a global disease, especially in children. Many patients with IBDs develop extraintestinal manifestations (EIMs) during follow-up, as IBDs have a potential risk of systemic involvement..
Data sources
A systematic review of the literature was made to analyze latest studies on pancreatic involvement in children with IBD including our experience in assessing possible implications and its future application.
Results
The involvement of the hepatobiliary system is considered a rare EIM of children with IBD, with an incidence much higher than that in the general population. Isolated pancreatic hyperenzymemia, which occurs in the absence of typical symptoms and/or characteristic imaging findings, may be found in many patients with IBD. The frequent causes of pancreatitis are drugs, bilio-pancreatic disorders, immunologic disturbances and pancreatic auto-antibodies, although in some cases idiopathic forms have been described.
Conclusions
It is important to establish a correct diagnostic approach based on etiology and to assess the most appropriate therapeutic strategy, thus avoiding complications and improving the quality of life of children with IBD.
Similar content being viewed by others
References
Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 2011;17:2702–2707.
Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr 2010;51:140–145.
Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:63–68.
Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz-Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011;106:110–119.
Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:307–327.
Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:1598–1619.
Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1–33.
Morinville VD, Husain SZ, Bai H, Barth B, Alhosh R, Durie PR, et al. Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr 2012;55:261–265.
Le Large-Guiheneuf C, Hugot JP, Faure C, Munck A, Mougenot JF, Navarro J, et al. Pancreatic involvement in inflammatory bowel diseases in children. Arch Pediatr 2002;9:469–477. [In French]
Stawarski A, Iwanczak F. Incidence of acute pancreatitis in children with inflammatory bowel disease. Pol Merkur Lekarski 2004;17:33–36. [In Polish]
Herrlinger KR, Stange EF. The pancreas and inflammatory bowel diseases. Int J Pancreatol 2000;27:171–179.
Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40:352–358.
Broide E, Dotan I, Weiss B, Wilschanski M, Yerushalmi B, Klar A, et al. Idiopathic pancreatitis preceding the diagnosis of inflammatory bowel disease is more frequent in pediatric patients. J Pediatr Gastroenterol Nutr 2011;52:714–717.
Knafelz D, Panetta F, Monti L, Bracci F, Papadatou B, Torre G, et al. Chronic pancreatitis as presentation of Crohn’s disease in a child. World J Gastroenterol 2013;19:5204–5206.
Frossard JL, Felley C, Michetti P. Recurrent acute pancreatitis and therapy for ulcerative colitis. Case Rep Gastroenterol 2010;4:304–306.
Bai HX, Ma MH, Orabi AI, Park A, Latif SU, Bhandari V, et al. Novel characterization of drug-associated pancreatitis in children. J Pediatr Gastroenterol Nutr 2011;53:423–428.
Keljo DJ, Sugerman KS. Pancreatitis in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1997;25:108–112.
van Geenen EJ, de Boer NK, Stassen P, Linskens RK, Bruno MJ, Mulder CJ, et al. Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon. Aliment Pharmacol Ther 2010;31:1322–1329.
Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012;55:340–361.
Ledder OD, Lemberg DA, Ooi CY, Day AS. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease? J Pediatr Gastroenterol Nutr 2013;57:583–586.
Ooi CY, Bohane TD, Lee D, Naidoo D, Day AS. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. Aliment Pharmacol Ther 2007;25:941–947.
Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther 2008;28:623–628.
Pitchumoni CS, Rubin A, Das K. Pancreatitis in inflammatory bowel diseases. J Clin Gastroenterol 2010;44:246–253.
Evans JS, George DE, Barwick KW, Lafer DJ. Crohn’s disease presenting as chronic pancreatitis with biliary tract obstruction. J Pediatr Gastroenterol Nutr 1996;22:384–388.
Heikius B, Niemelä S, Lehtola J, Karttunen T, Lähde S. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease. Scand J Gastroenterol 1997;32:153–161.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237–267.
Ravi K, Chari ST, Vege SS, Sandborn WJ, Smyrk TC, Loftus EV Jr. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis 2009;15:1326–1330.
Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo clinic experience. Clin Gastroenterol Hepatol 2006;4:1010–1016.
Kovacs M, Lakatos PL, Papp M, Jacobsen S, Nemes E, Polgar M, et al. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:429–435.
Smyk DS, Rigopoulou EI, Koutsoumpas AL, Kriese S, Burroughs AK, Bogdanos DP. Autoantibodies in autoimmune pancreatitis. Int J Rheumatol 2012;2012: 940831.
Heikius B, Niemelä S, Lehtola J, Karttunen TJ. Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease. Am J Gastroenterol 1999;94:1062–1069.
Triantafi-llidis JK, Merikas E, Malagarinos G, Panteris V, Peros G. Acute idiopathic pancreatitis preceding diagnosis of Crohn’s Disease. Description of three cases. Rev Med Chir Soc Med Nat Iasi 2009;113:97–102.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cardile, S., Randazzo, A., Valenti, S. et al. Pancreatic involvement in pediatric inflammatory bowel diseases. World J Pediatr 11, 207–211 (2015). https://doi.org/10.1007/s12519-015-0029-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-015-0029-z